Stifel Reiterates Buy Rating on Incyte (INCY)
Positive stance with meaningful upside to target.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Positive stance with meaningful upside to target.
What happened, with direct paths to the underlying reporting
Stifel Nicolaus reiterates Buy on INCY; target $123; current price $103.07.
Target: $123
Posted price: $103.07
Analyst firm: Stifel Nicolaus
Analyst: Stephen Willey
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.